Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification.
Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A. · 2017
Read Next-Generation Sequencing in Oncology: Genetic Diagnosis, Risk Prediction and Cancer Classification. by Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A. (2017) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc5343844.txt.
Description
Rick Kamps and co-authors reviewed fast gene reading in cancer care in the International Journal of Molecular Sciences in 2017. New machines read millions of DNA chunks at once, with far better speed, cost, and trust than older methods. That leap has brought gene reading into daily clinic work. The review sorts its uses in oncology, field by field.
Panel and whole-code reading can find the flaws behind inherited cancer risk in a family. RNA reading spots bad splicing of gene messages. The same tools scan a tumor's own flaws, guess how a patient will handle a drug, and test blood for loose tumor DNA. Uses reach even to embryo checks before pregnancy. The authors close with the limits: reading the data well, training doctors, and the ethics of what tests turn up by chance.
Catalog record
| CREATOR | Kamps R, Brandão RD, Bosch BJ, Paulussen AD, Xanthoulea S, Blok MJ, Romano A. |
|---|---|
| YEAR | 2017 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 179 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |